Market Overview:
The global implantable cardiac stimulators market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cardiovascular diseases, technological advancements in cardiac stimulators, and increasing demand for minimally invasive procedures. Based on type, the global implantable cardiac stimulators market is segmented into ICDs (implantable cardioverter-defibrillator), pacemakers, CRT-Ds (cardiac resynchronization therapy devices), and CRT-Ps (cardiac resynchronization therapy pacemakers). The ICDs segment is expected to account for the largest share of the global implantable cardiac stimulators market in 2018. This can be attributed to the high prevalence of arrhythmia and other heart conditions that require an ICD for treatment. Based on application, the global implantable cardiac stimulators market is segmented into hospitals, clinics, and others. The hospitals segment accounted for the largest share of the global implantable cardiac stimulator market in 2017 and is projected to grow at a CAGR of 5.8% from 2018 to 2030.
Product Definition:
An implantable cardiac stimulator (ICS) is a device that is implanted under the skin to help regulate a person's heartbeat. ICS devices are used to treat arrhythmias, which are heart rhythm disorders. An arrhythmia can cause the heart to beat too fast, too slow, or irregularly.
ICD:
ICD is an electronic device that generates regular and fast heartbeats to treat bradycardia, tachycardia or cardiac fibrillation. ICDs are most commonly used for the treatment of sinus node dysfunction (SND) and conduction disorders. The implantation of these devices is done in patients suffering from conditions such as atrial fibrillation, slow ventricular rate, flutter or heart blockage due to excessive alcohol consumption etc.
Pacemaker:
A pacemaker is a small electronic device that is used to provide an electric signal to the heart muscles in order to initiate and maintain a regular heartbeat. Pacemakers are also referred as pace makers or cardiac pacemakers. They are most commonly used in patients who have suffered from heart failure, have slow sinus node function, or have arrhythmias (irregular heartbeat).
Application Insights:
The hospital segment dominated the global market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to factors such as a high prevalence of cardiac diseases, which require ICDs for treatment, and increasing investments by government agencies and private institutions in healthcare infrastructure development. For instance, according to WHO, around 300 million people suffer from some form of arrhythmia globally. Thus, there is a huge demand for implantable cardiac stimulators that can treat various types of arrhythmias effectively.
Furthermore, an increase in patient awareness levels coupled with rising availability of advanced products has led to an increased adoption rate among patients suffering from life-threatening heart conditions across the globe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable reimbursement policies, high patient awareness levels coupled with a large patient pool that is covered by insurance and an increase in FDA approvals for various devices. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to increasing geriatric population, technological advancements such as Bluetooth connectivity and voice recognition systems, improving healthcare infrastructure along with rising disposable income of patients & their families. Moreover, government initiatives are being undertaken in this region for tackling heart diseases which include “Heart Month†activities held throughout February each year across countries such as India and China.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive surgeries
- Technological advancements in implantable cardiac stimulators
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Cardiac Stimulators Market Research Report
By Type
ICD, Pacemaker, CRT-D, CRT-P
By Application
Hospital, Clinic, Others
By Companies
Vitatron, Biotronik, Medtronic, Lepu Medical Technology, Cameron Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Cardiac Stimulators Market Report Segments:
The global Implantable Cardiac Stimulators market is segmented on the basis of:
Types
ICD, Pacemaker, CRT-D, CRT-P
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vitatron
- Biotronik
- Medtronic
- Lepu Medical Technology
- Cameron Health
Highlights of The Implantable Cardiac Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ICD
- Pacemaker
- CRT-D
- CRT-P
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Cardiac Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Implantable cardiac stimulators are medical devices that help to improve the heart's rhythm. They are often used in people who have heart failure or who have had a heart attack.
Some of the major players in the implantable cardiac stimulators market are Vitatron, Biotronik, Medtronic, Lepu Medical Technology, Cameron Health.
The implantable cardiac stimulators market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Cardiac Stimulators Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Cardiac Stimulators Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Cardiac Stimulators Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Cardiac Stimulators Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Cardiac Stimulators Market Size & Forecast, 2018-2028
4.5.1 Implantable Cardiac Stimulators Market Size and Y-o-Y Growth
4.5.2 Implantable Cardiac Stimulators Market Absolute $ Opportunity
Chapter 5 Global Implantable Cardiac Stimulators Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Implantable Cardiac Stimulators Market Size Forecast by Type
5.2.1 ICD
5.2.2 Pacemaker
5.2.3 CRT-D
5.2.4 CRT-P
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Implantable Cardiac Stimulators Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Implantable Cardiac Stimulators Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Cardiac Stimulators Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Cardiac Stimulators Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Implantable Cardiac Stimulators Analysis and Forecast
9.1 Introduction
9.2 North America Implantable Cardiac Stimulators Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Implantable Cardiac Stimulators Market Size Forecast by Type
9.6.1 ICD
9.6.2 Pacemaker
9.6.3 CRT-D
9.6.4 CRT-P
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Implantable Cardiac Stimulators Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Implantable Cardiac Stimulators Analysis and Forecast
10.1 Introduction
10.2 Europe Implantable Cardiac Stimulators Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Implantable Cardiac Stimulators Market Size Forecast by Type
10.6.1 ICD
10.6.2 Pacemaker
10.6.3 CRT-D
10.6.4 CRT-P
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Implantable Cardiac Stimulators Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Implantable Cardiac Stimulators Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Implantable Cardiac Stimulators Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Implantable Cardiac Stimulators Market Size Forecast by Type
11.6.1 ICD
11.6.2 Pacemaker
11.6.3 CRT-D
11.6.4 CRT-P
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Implantable Cardiac Stimulators Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Implantable Cardiac Stimulators Analysis and Forecast
12.1 Introduction
12.2 Latin America Implantable Cardiac Stimulators Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Implantable Cardiac Stimulators Market Size Forecast by Type
12.6.1 ICD
12.6.2 Pacemaker
12.6.3 CRT-D
12.6.4 CRT-P
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Implantable Cardiac Stimulators Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Implantable Cardiac Stimulators Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Implantable Cardiac Stimulators Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Implantable Cardiac Stimulators Market Size Forecast by Type
13.6.1 ICD
13.6.2 Pacemaker
13.6.3 CRT-D
13.6.4 CRT-P
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Implantable Cardiac Stimulators Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Cardiac Stimulators Market: Competitive Dashboard
14.2 Global Implantable Cardiac Stimulators Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vitatron
14.3.2 Biotronik
14.3.3 Medtronic
14.3.4 Lepu Medical Technology
14.3.5 Cameron Health
